Martin van den Berg PhD (Editor-in-Chief, Regulatory Toxicology & Pharmacology and Current Opinion in Toxicology) , Daniel R. Dietrich PhD (Editor-in-Chief, Chemico-Biological Interactions, Computational Toxicology, and Journal of Toxicology and Regulatory Policy) , Sonja von Aulock PhD (Editor-in-Chief, ALTEX – Alternatives to Animal Experimentation) , Anna Bal-Price PhD (Editor-in-Chief, Reproductive Toxicology) , Michael D. Coleman PhD (Editor-in-Chief, Environmental Toxicology and Pharmacology) , Mark T.D. Cronin PhD (Editor-in-Chief, Computational Toxicology) , Paul Jennings PhD (Editor-in-Chief, Toxicology in Vitro) , Angela Mally PhD (Editor-in-Chief, Toxicology Letters) , Mathieu Vinken PhD (Editor-in-Chief, Toxicology and NAM Journal) , Matthew C. Wright PhD (Editor-in-Chief, Food and Chemical Toxicology)
{"title":"The Alarming Consequences of Workforce Reductions at the FDA, EPA, NIH and CDC in the United States","authors":"Martin van den Berg PhD (Editor-in-Chief, Regulatory Toxicology & Pharmacology and Current Opinion in Toxicology) , Daniel R. Dietrich PhD (Editor-in-Chief, Chemico-Biological Interactions, Computational Toxicology, and Journal of Toxicology and Regulatory Policy) , Sonja von Aulock PhD (Editor-in-Chief, ALTEX – Alternatives to Animal Experimentation) , Anna Bal-Price PhD (Editor-in-Chief, Reproductive Toxicology) , Michael D. Coleman PhD (Editor-in-Chief, Environmental Toxicology and Pharmacology) , Mark T.D. Cronin PhD (Editor-in-Chief, Computational Toxicology) , Paul Jennings PhD (Editor-in-Chief, Toxicology in Vitro) , Angela Mally PhD (Editor-in-Chief, Toxicology Letters) , Mathieu Vinken PhD (Editor-in-Chief, Toxicology and NAM Journal) , Matthew C. Wright PhD (Editor-in-Chief, Food and Chemical Toxicology)","doi":"10.1016/j.yrtph.2025.105827","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":20852,"journal":{"name":"Regulatory Toxicology and Pharmacology","volume":"160 ","pages":"Article 105827"},"PeriodicalIF":3.0000,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Regulatory Toxicology and Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0273230025000571","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, LEGAL","Score":null,"Total":0}
期刊介绍:
Regulatory Toxicology and Pharmacology publishes peer reviewed articles that involve the generation, evaluation, and interpretation of experimental animal and human data that are of direct importance and relevance for regulatory authorities with respect to toxicological and pharmacological regulations in society. All peer-reviewed articles that are published should be devoted to improve the protection of human health and environment. Reviews and discussions are welcomed that address legal and/or regulatory decisions with respect to risk assessment and management of toxicological and pharmacological compounds on a scientific basis. It addresses an international readership of scientists, risk assessors and managers, and other professionals active in the field of human and environmental health.
Types of peer-reviewed articles published:
-Original research articles of relevance for regulatory aspects covering aspects including, but not limited to:
1.Factors influencing human sensitivity
2.Exposure science related to risk assessment
3.Alternative toxicological test methods
4.Frameworks for evaluation and integration of data in regulatory evaluations
5.Harmonization across regulatory agencies
6.Read-across methods and evaluations
-Contemporary Reviews on policy related Research issues
-Letters to the Editor
-Guest Editorials (by Invitation)